tradingkey.logo

Simulations Plus Inc

SLP
查看詳細走勢圖
14.570USD
+0.430+3.04%
收盤 02/06, 16:00美東報價延遲15分鐘
293.54M總市值
虧損本益比TTM

Simulations Plus Inc

14.570
+0.430+3.04%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.04%

5天

-13.74%

1月

-23.28%

6月

+3.63%

今年開始到現在

-20.08%

1年

-59.83%

查看詳細走勢圖

TradingKey Simulations Plus Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Simulations Plus Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名70/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為24.75。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Simulations Plus Inc評分

相關信息

行業排名
70 / 205
全市場排名
185 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Simulations Plus Inc亮點

亮點風險
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
業績高增長
公司營業收入穩步增長,連續3年增長32.90%
業績增長期
公司處於發展階段,最新年度總收入79.18M美元
業績轉虧
公司業績轉虧,最新年度虧損美元
估值低估
公司最新PE估值-4.56,處於3年歷史低位
機構減倉
最新機構持股15.79M股,環比減少20.73%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉1.66K股
活躍度降低
近期活躍度降低,過去20天平均換手率0.61

分析師目標

基於 7 分析師
買入
評級
24.750
目標均價
+67.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Simulations Plus Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Simulations Plus Inc簡介

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
公司代碼SLP
公司Simulations Plus Inc
CEOO'Connor (Shawn M)
網址https://www.simulations-plus.com/
KeyAI